Reports have said that Beijing is speaking out against the US court that recently ordered two Chinese manufacturers of Vitamin C to pay $162 million in damages for price-fixing. The US court is now accused of infringing on Beijing’s sovereignty. A spokesman for China’s Ministry of Commerce spoke out against the US court at a press conference, arguing that the ruling was “unfair and improper” and that the accused companies were simply complying with the Chinese government’s requirements. Last week a federal court in New York ordered that North China Pharmaceutical Group Corp and one of its affiliates to pay the fine after the defendants argued that the “price-fixing cartel” found to have existed by the jury was the result of Chinese government decisions. The fines were trebled by the judge.
Featured News
Tenth Circuit Ruling Allows Colorado to Enforce Interest Rate Caps
Nov 12, 2025 by
CPI
Hong Kong’s Competition Commission Pressures Keeta to Drop Anti-Competitive Clauses
Nov 12, 2025 by
CPI
Recovery Firms Accused of Exploiting Class Members in Generic Drug Price-Fixing Case
Nov 12, 2025 by
CPI
India’s Antitrust Regulator Raids Paper Mills Over Alleged Price Collusion
Nov 12, 2025 by
CPI
California’s New CCPA Rules Bring Corporate Accountability to the Individual Level
Nov 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Entertainment & Culture
Nov 13, 2025 by
CPI
Non-Playable Character: Competition Law Enforcement in the Video Game Market
Nov 13, 2025 by
Robin S. Crauthers
Gerrymandering Sports Entertainment Product Markets
Nov 13, 2025 by
Jodi Balsam
Redistribution via Competition Policy: A Case Study of Creative Industries
Nov 13, 2025 by
Friso Bostoen
Sports Governing Bodies vs. Antitrust 0 – 4? Sport and Competition Economics Comments on the Recent Judgements of the European Court of Justice
Nov 13, 2025 by
Oliver Budzinski